A Phase I Study of Guadecitabine Combined with Irinotecan Followed by A Randomized Phase II Study of Sgi-110 Combined with Irinotecan Versus Regorafenib or TAS-102 in Previously Treated Metastatic Colorectal Cancer Patients - Stand Up To Cancer

Blog

Posted October 14, 2019

A Phase I Study of Guadecitabine Combined with Irinotecan Followed by A Randomized Phase II Study of Sgi-110 Combined with Irinotecan Versus Regorafenib or TAS-102 in Previously Treated Metastatic Colorectal Cancer Patients

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.